Swiss officials: Covid vaccine protects for 12 months
A man receives a plaster after getting his jab in Bern
Keystone / Peter Klaunzer
Coronavirus vaccines could offer at least 12 months of protection against all forms of the virus, a top Swiss health official says. This increases the former official line of six months of protection.
The Federal Vaccination Commission has concluded that people are protected for at least a year against infection – and more than that against severe cases, said Virginie Masserey, head of the Federal Office of Public Health’s Infectious Diseases Section, at a press conference on Tuesday.
It will therefore not be necessary to have a booster jab before 2022, she added.
Ordinances on the issue will be changed to reflect this change of view.
More than half of adults have already received at least one dose of the vaccine, Masserey explained. This rises to at least 80% for vulnerable groups. The vaccination campaign is proceeding well, with around 100,000 vaccinations a day, the official said. There are no indications that vaccine willingness is dropping off.
Covid certificate
The development of the forgery proof Covid certificate is also going well, with more than 650,000 already sent out, Masserey said. “We are confident that all those who want can have access to a certificate by the end of the month,” she said. This is to be given to anyone who has been vaccinated, has recovered from or has recently tested negative for coronavirus. The validity length of the certificate would also be changed due to the protection advice change.
Trend, variants
Meanwhile downward trend in case numbers is continuing. There were 243 reported Covid-19 casesExternal link on Tuesday, 14 hospitalisations and two deaths. New infections have stayed below 1,000 since May 26.
Masserey added that until now the number of cases linked to new variants of the coronavirus like the Delta variant were relatively low. Vaccines were also effective against these variants, but people still had to be careful as not everyone had yet been vaccinated, she added
More
More
Coronavirus: the situation in Switzerland
This content was published on
An overview of the latest Covid-related information in the Alpine nation.
Is artificial intelligence an advantage or a disadvantage for workers?
What is your experience with AI at work? Have you already used it? Has it helped you work better? Or has it caused you more stress, more work or caused you to lose your job? Tell us about your experiences!
Swiss price watchdog slams excessive prices for generic medicines
This content was published on
The cheapest generic medicines available in Switzerland are more than twice as expensive as in other countries, according to a study by the Swiss price watchdog.
Nature should not figure in net zero calculations: academic study
This content was published on
The natural removal of CO2 from the atmosphere by forests or oceans should not be included in the net-zero balance of climate protection measures, argue researchers.
This content was published on
None of the 15 major Swiss retail banks is meeting international climate and biodiversity targets, according to a ranking by WWF Switzerland.
This content was published on
Nestlé's new CEO Laurent Freixe, has presented plans for the future of the world's largest food company, after his first few weeks in office.
Swiss foreign minister calls on Moscow to end Ukraine war
This content was published on
It's high time Moscow ended its war against Ukraine, Swiss foreign minister Ignazio Cassis tells the UN Security Council.
This content was published on
The only alternative to the UN Palestinian agency’s work in Gaza is to allow Israel to run services there, Philippe Lazzarini, UNRWA Commissioner-General, told reporters in Geneva on Monday.
Study reveals food culture differences between Switzerland and neighbours
This content was published on
Three-quarters of Swiss people consider eating to be a pleasurable, social activity, a new survey reveals. Healthy eating, however, plays a much less important role, it found.
This content was published on
US-based biotech company Moderna is applying for the use of its Covid-19 vaccine for adolescents aged 12 to 17 in Switzerland.
You can find an overview of ongoing debates with our journalists here . Please join us!
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.